Author: Vignatelli, Luca; Zenesini, Corrado; Belotti, Laura M.B.; Baldin, Elisa; Bonavina, Giuseppe; Calandraâ€Buonaura, Giovanna; Cortelli, Pietro; Descovich, Carlo; Fabbri, Giovanni; Giannini, Giulia; Guarino, Maria; Pantieri, Roberta; Samoggia, Giuseppe; Scaglione, Cesa; Trombetti, Susanna; D'Alessandro, Roberto; Nonino, Francesco
Title: Risk of Hospitalization and Death for COVIDâ€19 in People With Parkinson's Disease or Parkinsonism Cord-id: qij4d3a2 Document date: 2020_12_2
ID: qij4d3a2
Snippet: BACKGROUND: The risk of COVIDâ€19 and related death in people with Parkinson's disease or parkinsonism is uncertain. The aim of the study was to assess the risk of hospitalization for COVIDâ€19 and death in a cohort of patients with Parkinson's disease or parkinsonism compared with a control population cohort, during the epidemic bout (March–May 2020) in Bologna, northern Italy. METHODS: Participants of the ParkLink study with the clinical diagnosis of Parkinson's disease or parkinsonism and
Document: BACKGROUND: The risk of COVIDâ€19 and related death in people with Parkinson's disease or parkinsonism is uncertain. The aim of the study was to assess the risk of hospitalization for COVIDâ€19 and death in a cohort of patients with Parkinson's disease or parkinsonism compared with a control population cohort, during the epidemic bout (March–May 2020) in Bologna, northern Italy. METHODS: Participants of the ParkLink study with the clinical diagnosis of Parkinson's disease or parkinsonism and people anonymously matched (ratio 1:10) for sex, age, district, and Charlson Index were included. The hospital admission rate for COVIDâ€19 (February 26–May 31, 2020) and the death rate for any cause were the outcomes of interest. RESULTS: The ParkLink cohort included 696 subjects with Parkinson's disease and 184 with parkinsonism, and the control cohort had 8590 subjects. The 3â€month hospitalization rate for COVIDâ€19 was 0.6% in Parkinson's disease, 3.3% in parkinsonism, and 0.7% in controls. The adjusted hazard ratio (age, sex, district, Charlson Index) was 0.8 (95% CI, 0.3–2.3, P = 0.74) in Parkinson's disease and 3.3 (1.4–7.6, P = 0.006) in parkinsonism compared with controls. Twentyâ€nine of the infected subjects died; 30â€day fatality rate was 35.1%, without difference among the 3 groups. Six of 10 Parkinson's disease/parkinsonism patients had the infection during hospitalization or in a nursing home. CONCLUSIONS: Parkinson's disease per se probably is not a risk factor for COVIDâ€19 hospitalization. Conversely, parkinsonism is an independent risk factor probably because of a more severe health status, entailing higher care dependence and placement in highâ€infectionâ€risk accommodations. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC. on behalf of International Parkinson and Movement Disorder Society.
Search related documents:
Co phrase search for related documents- academic hospital and lockdown period: 1, 2, 3
- administrative database and lockdown period: 1
- admission rate and lockdown period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date